600594 益佰制药
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资34,683-0.34%34,80235,10135,07135,413
投资性房地产0--0000
固定资产1,405,959-2.72%1,445,2081,602,5461,705,6851,639,762
在建工程2,74625.91%2,1816994,988145,942
无形资产308,259-1.29%312,294319,558330,887362,032
商誉0--0131,263164,038164,038
其他非流动资产203,4991.94%199,633260,507287,437299,211
1,955,147-1.95%1,994,1182,349,6752,528,1062,646,398

流动资产
货币资金489,8979.56%447,133521,007699,469592,355
应收账款130,008-22.31%167,338191,361227,056294,527
存货540,242-1.22%546,903607,775586,651625,085
其他流动资产282,932-1.19%286,345429,882555,973528,664
1,443,079-0.32%1,447,7181,750,0262,069,1482,040,631

流动负债
短期借款438,8706.03%413,928380,929446,045537,110
应付票据0--0000
应付帐款82,595-19.80%102,986124,483135,058149,428
其他流动负债326,486-16.70%391,961443,600348,487486,178
847,951-6.70%908,875949,012929,5901,172,715
流动资产净值595,12810.45%538,842801,0141,139,558867,916
资产总额减流动负债2,550,2750.68%2,532,9603,150,6893,667,6643,514,314

非流动负债
长期借款150,18949.98%100,139307,517387,225343,038
应付债券0--0000
其他非流动负债158,445-2.33%162,217237,062262,185164,034
308,63417.64%262,356544,578649,409507,073

总权益
    实收股本791,9270.00%791,927791,927791,927791,927
    储备项目1,366,335-2.12%1,395,8591,697,8312,092,5172,069,462
股东权益2,158,262-1.35%2,187,7872,489,7582,884,4442,861,389
非控股权益83,3790.68%82,817116,352133,810145,852